Lintsen A M E, Eijkemans M J C, Hunault C C, Bouwmans C A M, Hakkaart L, Habbema J D F, Braat D D M
Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen 6500 HB, The Netherlands.
Hum Reprod. 2007 Sep;22(9):2455-62. doi: 10.1093/humrep/dem183. Epub 2007 Jul 17.
The Dutch IVF guideline suggests triage of patients for IVF based on diagnostic category, duration of infertility and female age. There is no evidence for the effectiveness of these criteria. We evaluated the predictive value of patient characteristics that are used in the Dutch IVF guideline and developed a model that predicts the IVF ongoing pregnancy chance within 12 months.
In a national prospective cohort study, pregnancy chances after IVF and ICSI treatment were assessed. Couples eligible for IVF or ICSI were followed during 12 months, using the databases of 11 IVF centres and 20 transport IVF clinics. Kaplan-Meier analysis was performed to estimate the cumulative probability of an ongoing pregnancy, and Cox regression was used for assessing the effects of predictors of pregnancy.
4928 couples starting IVF/ICSI treatment were prospectively followed. On average, couples had 1.8 cycles in 12 months for both IVF and ICSI. The 1-year probability of ongoing pregnancy was 44.8% (95% CI 42.1-47.5%). ICSI for severe oligospermia had a significantly higher ongoing pregnancy rate than IVF indicated treatments, with a multivariate Hazard ratio (HR) of 1.22 (95% CI 1.07-1.39). The success rates were comparable for all diagnostic categories of IVF. The highest success rate is at age 30, with a slight decline towards younger women and women up to 35 and a sharp drop after 35. Primary subfertility with a HR of 0.90 (95% CI 0.83-0.99) and duration of subfertility with a HR of 0.97 (95% CI 0.95-0.99) per year significantly affected the pregnancy chance.
The most important predictors of the pregnancy chance after IVF and ICSI are women's age and ICSI. The diagnostic category is of no consequence. Duration of subfertility and pregnancy history are of limited prognostic value.
荷兰体外受精指南建议根据诊断类别、不孕持续时间和女性年龄对体外受精患者进行分类。尚无证据表明这些标准的有效性。我们评估了荷兰体外受精指南中使用的患者特征的预测价值,并开发了一个模型来预测12个月内体外受精持续妊娠的几率。
在一项全国性前瞻性队列研究中,评估了体外受精和卵胞浆内单精子注射(ICSI)治疗后的妊娠几率。利用11个体外受精中心和20个转运体外受精诊所的数据库,对符合体外受精或ICSI条件的夫妇进行了12个月的随访。采用Kaplan-Meier分析来估计持续妊娠的累积概率,并使用Cox回归来评估妊娠预测因素的影响。
对4928对开始体外受精/ICSI治疗的夫妇进行了前瞻性随访。平均而言,体外受精和ICSI夫妇在12个月内均有1.8个周期。持续妊娠的1年概率为44.8%(95%置信区间42.1-47.5%)。重度少精子症的ICSI治疗的持续妊娠率显著高于体外受精指定治疗,多变量风险比(HR)为1.22(95%置信区间1.07-1.39)。体外受精的所有诊断类别成功率相当。成功率最高的是30岁,向年轻女性和35岁以下女性略有下降,35岁后急剧下降。原发性亚生育的HR为0.90(95%置信区间0.83-0.99),亚生育持续时间每年的HR为0.97(95%置信区间0.95-0.99),均显著影响妊娠几率。
体外受精和ICSI后妊娠几率的最重要预测因素是女性年龄和ICSI。诊断类别无关紧要。亚生育持续时间和妊娠史的预后价值有限。